229 related articles for article (PubMed ID: 30671048)
21. Development of a mass spectrometric screening assay for hepatitis B virus entry inhibitors.
Goh B; Choi J; Kang JA; Park SG; Seo J; Kim TY
J Pharm Biomed Anal; 2020 Jan; 178():112959. PubMed ID: 31722821
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of HBV transcription by sodium taurocholate cotransporting polypeptide at the postentry step is inhibited by the entry inhibitor Myrcludex B.
Zhao K; Liu S; Chen Y; Yao Y; Zhou M; Yuan Y; Wang Y; Pei R; Chen J; Hu X; Zhou Y; Zhao H; Lu M; Wu C; Chen X
Emerg Microbes Infect; 2018 Nov; 7(1):186. PubMed ID: 30459339
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B virus efficiently infects non-adherent hepatoma cells via human sodium taurocholate cotransporting polypeptide.
Okuyama-Dobashi K; Kasai H; Tanaka T; Yamashita A; Yasumoto J; Chen W; Okamoto T; Maekawa S; Watashi K; Wakita T; Ryo A; Suzuki T; Matsuura Y; Enomoto N; Moriishi K
Sci Rep; 2015 Nov; 5():17047. PubMed ID: 26592202
[TBL] [Abstract][Full Text] [Related]
24. Development of a cell-based assay to identify hepatitis B virus entry inhibitors targeting the sodium taurocholate cotransporting polypeptide.
Miyakawa K; Matsunaga S; Yamaoka Y; Dairaku M; Fukano K; Kimura H; Chimuro T; Nishitsuji H; Watashi K; Shimotohno K; Wakita T; Ryo A
Oncotarget; 2018 May; 9(34):23681-23694. PubMed ID: 29805766
[TBL] [Abstract][Full Text] [Related]
25. Fungal Secondary Metabolite Exophillic Acid Selectively Inhibits the Entry of Hepatitis B and D Viruses.
Kobayashi C; Watanabe Y; Oshima M; Hirose T; Yamasaki M; Iwamoto M; Iwatsuki M; Asami Y; Kuramochi K; Wakae K; Aizaki H; Muramatsu M; Sureau C; Sunazuka T; Watashi K
Viruses; 2022 Apr; 14(4):. PubMed ID: 35458494
[TBL] [Abstract][Full Text] [Related]
26. From DCPD to NTCP: the long journey towards identifying a functional hepatitis B virus receptor.
Li J; Tong S
Clin Mol Hepatol; 2015 Sep; 21(3):193-9. PubMed ID: 26523264
[TBL] [Abstract][Full Text] [Related]
27. Sodium taurocholate cotransporting polypeptide acts as a receptor for hepatitis B and D virus.
Yan H; Li W
Dig Dis; 2015; 33(3):388-96. PubMed ID: 26045274
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of fasiglifam on hepatitis B virus infections through suppression of the sodium taurocholate cotransporting polypeptide.
Nio Y; Akahori Y; Okamura H; Watashi K; Wakita T; Hijikata M
Biochem Biophys Res Commun; 2018 Jun; 501(3):820-825. PubMed ID: 29723527
[TBL] [Abstract][Full Text] [Related]
29. Interleukin 6 inhibits HBV entry through NTCP down regulation.
Bouezzedine F; Fardel O; Gripon P
Virology; 2015 Jul; 481():34-42. PubMed ID: 25765005
[TBL] [Abstract][Full Text] [Related]
30. Establishment of a human cell line with a surface display system for screening and optimizing Na
Wang PY; Yang X; Guo L; Wang YW; Zhang WL; Sun YX; Li J; Gan CY; Long SY; Liu JJ; Fan SY; Huang AL; Hu JL
Front Microbiol; 2022; 13():920280. PubMed ID: 36060770
[TBL] [Abstract][Full Text] [Related]
31. Sodium taurocholate cotransporting polypeptide is the limiting host factor of hepatitis B virus infection in macaque and pig hepatocytes.
Lempp FA; Wiedtke E; Qu B; Roques P; Chemin I; Vondran FWR; Le Grand R; Grimm D; Urban S
Hepatology; 2017 Sep; 66(3):703-716. PubMed ID: 28195359
[TBL] [Abstract][Full Text] [Related]
32. Woodchuck sodium taurocholate cotransporting polypeptide supports low-level hepatitis B and D virus entry.
Fu L; Hu H; Liu Y; Jing Z; Li W
Virology; 2017 May; 505():1-11. PubMed ID: 28213271
[TBL] [Abstract][Full Text] [Related]
33. Live Cell Imaging Confocal Microscopy Analysis of HBV Myr-PreS1 Peptide Binding and Uptake in NTCP-GFP Expressing HepG2 Cells.
König A; Glebe D
Methods Mol Biol; 2017; 1540():27-36. PubMed ID: 27975305
[TBL] [Abstract][Full Text] [Related]
34. Cellular uptake of hepatitis B virus envelope L particles is independent of sodium taurocholate cotransporting polypeptide, but dependent on heparan sulfate proteoglycan.
Somiya M; Liu Q; Yoshimoto N; Iijima M; Tatematsu K; Nakai T; Okajima T; Kuroki K; Ueda K; Kuroda S
Virology; 2016 Oct; 497():23-32. PubMed ID: 27420796
[TBL] [Abstract][Full Text] [Related]
35. Robust Human and Murine Hepatocyte Culture Models of Hepatitis B Virus Infection and Replication.
Qiao L; Sui J; Luo G
J Virol; 2018 Dec; 92(23):. PubMed ID: 30232184
[TBL] [Abstract][Full Text] [Related]
36. Analysis of hepatitis B virus preS1 variability and prevalence of the rs2296651 polymorphism in a Spanish population.
Casillas R; Tabernero D; Gregori J; Belmonte I; Cortese MF; González C; Riveiro-Barciela M; López RM; Quer J; Esteban R; Buti M; Rodríguez-Frías F
World J Gastroenterol; 2018 Feb; 24(6):680-692. PubMed ID: 29456407
[TBL] [Abstract][Full Text] [Related]
37. De Novo Macrocyclic Peptide Inhibitors of Hepatitis B Virus Cellular Entry.
Passioura T; Watashi K; Fukano K; Shimura S; Saso W; Morishita R; Ogasawara Y; Tanaka Y; Mizokami M; Sureau C; Suga H; Wakita T
Cell Chem Biol; 2018 Jul; 25(7):906-915.e5. PubMed ID: 29779957
[TBL] [Abstract][Full Text] [Related]
38. Role of sodium taurocholate cotransporting polypeptide (NTCP) in HBV-induced hepatitis: Opportunities for developing novel therapeutics.
Zhang Z; Zhang Q; Zhang Y; Lou Y; Ge L; Zhang W; Zhang W; Song F; Huang P
Biochem Pharmacol; 2024 Jan; 219():115956. PubMed ID: 38049009
[TBL] [Abstract][Full Text] [Related]
39. Evans Blue Inhibits HBV Replication Through a Dual Antiviral Mechanism by Targeting Virus Binding and Capsid Assembly.
Xiao Y; Liu C; Tang W; Zhang H; Chen X
Front Microbiol; 2019; 10():2638. PubMed ID: 31798562
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory effect of a novel thiazolidinedione derivative on hepatitis B virus entry.
Tanaka T; Okuyama-Dobashi K; Motohashi R; Yokoe H; Takahashi K; Wiriyasermkul P; Kasai H; Yamashita A; Maekawa S; Enomoto N; Ryo A; Nagamori S; Tsubuki M; Moriishi K
Antiviral Res; 2021 Oct; 194():105165. PubMed ID: 34419484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
